BNOX....Life is tough for the Director ; )
At the date of this Notice, the details (including the amount) of the current total remuneration package of Dr De Souza (or his nominee) to whom Options would be issued is:
| | |
| Nature | Remuneration Package Details |
| Non-Executive Director fee | Non-Executive Director fee as Chair to be determined by the Board in the usual way |
Dr De Souza agreed to transition to Non-Executive Chair from 1 January 2023. In connection with that transition, for the period from 1 January 2023 to 30 June 2023, Dr De Souza will continue to receive a monthly fee of US$46,156.25 per month (inclusive of Non-Executive Director fees) plus US$2,166.67 per month for healthcare coverage. Dr De Souza will also receive 100% of his FY23 target bonus, subject to remaining as a director of the Company up to and including 30 June 2023. Dr De Souza will also retain equity awards previously granted.
At the date of this Notice, the details (including the amount) of the current total remuneration package of Dr De Souza (or his nominee) to whom Options would be issued is:
| | |
| Nature | Remuneration Package Details |
| Non-Executive Director fee | Non-Executive Director fee as Chair to be determined by the Board in the usual way |
Dr De Souza agreed to transition to Non-Executive Chair from 1 January 2023. In connection with that transition, for the period from 1 January 2023 to 30 June 2023, Dr De Souza will continue to receive a monthly fee of US$46,156.25 per month (inclusive of Non-Executive Director fees) plus US$2,166.67 per month for healthcare coverage. Dr De Souza will also receive 100% of his FY23 target bonus, subject to remaining as a director of the Company up to and including 30 June 2023. Dr De Souza will also retain equity awards previously granted.